Thoughts On Synergy Pharma's Valuation As Cantor Initiates At Overweight
June 02, 2017 at 09:49 AM EDT
Cantor Fitzgerald initiated coverage of Synergy Pharmaceuticals Inc (NASDAQ: SGYP) at Overweight with a price target of $11. Analyst ...